Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • strob
    Member
    • Nov 2008
    • 84

    FastQ drop (illumina)

    Hello all,

    when comparing the fastq files obtained from illumina/solexa sequencing, we see a huge drop in values. Normally, you would only see a small dip near the 3 prime end, while our current sequences show a dramatic drop when going to the 3 prime end and even their 5 prime end doesn't start at value ~40 (see att).

    After contacting people at illumina, they claim that the quality of the reads is still good, but that due to their new pipeline, you can have a drop in the fastq values.

    Some questions/remarks.

    - Did other people already experience this drop in fastq value?
    - How can we now standardize the quality of the reads when these values change over time?
    - What about assembly tools that try to incorporate these values in order to perform a better assembly?
    - How do you use/interpret these fastQ files?
    - Should we recalculate these values as described in following paper: http://www.ncbi.nlm.nih.gov/pubmed/1...ubmed_RVDocSum


    Many thanks

    Steven
    Attached Files
  • Torst
    Senior Member
    • Apr 2008
    • 275

    #2
    Illumina switched from "Solexa quality values" to "Phred quality values" since GAPipeline 1.3. They also changed the ASCII mapping. So your ASCII to "Q value" mapping could be misleading. See http://en.wikipedia.org/wiki/FASTQ_format

    Comment

    • Bacteria Genomes
      Junior Member
      • Jul 2009
      • 8

      #3
      I am also getting a drop in my quality scores as the cycles go but mine get really bad at the end. I attached graphs of the quality scores distributions. I got two slightly different patterns for the two different bacteria genera that I sequenced. I don't know why there would be a difference with the different genera unless the DNA preps weren't the same.

      I kind of don't know what to do with this information about the quality scores now though. At what point does the quality score mean the data is bad and shouldn't be used? Does anyone have a suggestion for how to trim the bad bases off?

      Note: I am aware that something went wrong around cycle 39, and that is not what my question is referring to.
      Attached Files

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      29 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      21 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      211 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      78 views
      0 reactions
      Last Post SEQadmin2  
      Working...